Join us on Wednesday, May 15, 2024, in Chicago, IL or via live stream! Click below for more information and to register.
Chronic inflammatory diseases of the upper and lower airways, including allergic rhinitis, chronic rhinosinusitis with nasal polyps (CRSwNP), and asthma, have been tied to significant risks and burdens for affected patients. Although biologic therapies that target overactive cytokine signaling are available, newer therapies are emerging, with targets upstream in the pathogenic cascade to improve efficacy across both T2-high and T2-low profiles. Join us for this engaging Expert Roundtable™ to hear multidisciplinary insights related to pathophysiologic processes in chronic inflammatory airway diseases, the rationale and evidence behind new biologic therapies, and integrated therapeutic strategies to achieve global disease control.
For more information about the approval of this program, please contact Integritas at info@exchangecme.com.
This activity is provided by Integritas Communications.
This activity is supported by an educational grant from AstraZeneca.
This program is not certified for continuing education credit. The content and opinions expressed are those of the sponsor and/or presenter(s) and are not necessarily those of COSM. There is no fee to attend this program; however, seating is limited. Preregistration does not guarantee seating. We recommend arriving at the symposium location early.
